Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

[1]  Gang Wu,et al.  Increased SHP-1 expression results in radioresistance, inhibition of cellular senescence, and cell cycle redistribution in nasopharyngeal carcinoma cells , 2015, Radiation Oncology.

[2]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.

[3]  J. Putnam,et al.  Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality. , 2014, The Journal of thoracic and cardiovascular surgery.

[4]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic radiation for early-stage non-small cell lung cancers in the elderly. , 2014 .

[5]  E. Smit,et al.  Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  James M. Galvin,et al.  RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients. , 2013 .

[7]  N. Altorki,et al.  Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  C. Sima,et al.  Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. , 2013, The Journal of thoracic and cardiovascular surgery.

[9]  Peter Balter,et al.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.

[10]  S. Senan,et al.  Developments in early-stage NSCLC: advances in radiotherapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Joe Y. Chang,et al.  Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[12]  Steven M Keller,et al.  Mediastinal staging of lung cancer: novel concepts. , 2012, The Lancet. Oncology.

[13]  Suresh Senan,et al.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[14]  John Cho,et al.  Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. , 2012, International journal of radiation oncology, biology, physics.

[15]  Hiroki Shirato,et al.  Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? , 2011, International journal of radiation oncology, biology, physics.

[16]  S. Senan,et al.  Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Jose Belderbos,et al.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Onimaru,et al.  A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403) , 2010 .

[19]  J. Bradley,et al.  Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. , 2010, The Journal of thoracic and cardiovascular surgery.

[20]  Alfons G H Kessels,et al.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[22]  B. Whitson,et al.  Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. , 2008, The Annals of thoracic surgery.

[23]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[24]  D. Boffa,et al.  Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. , 2008, The Journal of thoracic and cardiovascular surgery.

[25]  V. Rusch,et al.  Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. , 2006, The Annals of thoracic surgery.

[26]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[27]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.